×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

SQZ Biotechnologies Co. (SQZ) NEW YORK STOCK EXCHANGE INC.

$0.44 - (-)

Market Cap: $12.83M

As of 07/03/23 12:00 AM EDT. Market closed.

(SQZ)

SQZ Biotechnologies Co. (SQZ)
NEW YORK STOCK EXCHANGE INC.

$0.44
- (-)

Market Cap: $12.83M

As of 07/03/23 12:00 AM EDT. Market closed.

Add to Portfolio

spun out of mit, sqz biotechnologies is developing the next generation of cell therapies, using its propriety technology to harness the power of the patient's immune system to combat disease. sqz: empower cells to change ... read more

spun out of mit, sqz biotechnologies is developing the next generation of cell therapies, using its propriety technology to harness the power of the patient's immune system to combat disease. sqz: empower cells to change lives. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Full Time Employees
53
Address
.
PRICE CHART FOR SQZ BIOTECHNOLOGIES CO
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.39
Previous Close
$0.44
Days Range
$0.38 - $0.57
52 week range
$0.25 - $3.56
Volume
30,210,754
Avg. Volume (30 days)
1,707,324
Market Cap
$12.83M
Dividend Yield
-
P/E
-
Shares Outstanding
29,491,125
Open
$0.39
Previous Close
$0.44
Days Range
$0.38 - $0.57
52 week range
$0.25 - $3.56
Volume
30,210,754
Avg. Volume (30 days)
1,707,324
Market Cap
$12.83M
Dividend Yield
-
P/E
-
Shares Outstanding
29,491,125
FINANCIAL STATEMENTS FOR SQZ BIOTECHNOLOGIES CO
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR SQZ BIOTECHNOLOGIES CO
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Capasso RichardSee RemarksAug 15, 2022 Sale$3.331,1833,9350Aug 16, 2022, 05:15 PM
Sharei ArmonPresident and CEOJun 30, 2022 Option Exercise$2.702,4366,585287,884Jul 05, 2022, 05:00 PM
Knopf Lawrence JGeneral CounselJun 30, 2022 Option Exercise$2.701,4844,0111,938Jul 05, 2022, 05:00 PM
Capasso RichardSee RemarksJun 30, 2022 Option Exercise$2.701,1833,1981,183Jul 05, 2022, 05:00 PM
Jensen Klavs F.DirectorMay 25, 2022 Buy$3.5214,32650,428353,309May 27, 2022, 05:01 PM
Sharei ArmonPresident and CEOJan 12, 2022 Option Exercise$1.8113,00023,530285,448Jan 13, 2022, 05:15 PM
Sharei ArmonPresident and CEODec 31, 2021 Option Exercise$7.591,68612,798272,448Jan 04, 2022, 05:15 PM
Knopf Lawrence JGeneral CounselDec 31, 2021 Option Exercise$7.594543,446454Jan 04, 2022, 05:15 PM
SCHULMAN AMY WDirectorDec 22, 2021 Option Exercise$3.5224,13084,823214,814Dec 23, 2021, 05:15 PM
Sharei ArmonPresident and CEODec 22, 2021 Option Exercise$1.8111,04919,999270,762Dec 22, 2021, 05:15 PM
SCHULMAN AMY WDirectorDec 13, 2021 Buy$10.913,70040,3671,850Dec 15, 2021, 05:15 PM
Sharei ArmonPresident and CEOFeb 27, 2021 Option Exercise$1.818,00014,480259,713Mar 02, 2021, 05:32 PM
Sharei ArmonPresident and CEOJan 08, 2021 Option Exercise$1.812,5004,525251,713Jan 12, 2021, 04:30 PM
Temasek Holdings (Private) Ltd10% OwnerNov 03, 2020 Buy$16.00625,00010,000,0002,513,924Nov 05, 2020, 06:08 PM
AMERICAN INTERNATIONAL GROUP INC10% OwnerNov 03, 2020 Buy$16.00625,00010,000,000625,000Nov 04, 2020, 04:49 PM
SCHULMAN AMY WDirectorNov 03, 2020 Buy$16.00250,0004,000,0002,549,306Nov 03, 2020, 08:00 PM
Polaris Management Co. VII, L.L.C.10% OwnerNov 03, 2020 Buy$16.00250,0004,000,0002,549,306Nov 03, 2020, 08:00 PM
Invus Public Equities, L.P.10% OwnerNov 03, 2020 Buy$16.00465,0007,440,0001,606,308Nov 03, 2020, 08:00 PM
AMERICAN INTERNATIONAL GROUP INC10% OwnerOct 30, 2020 Buy$16.00625,00010,000,000625,000Nov 02, 2020, 04:34 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Capasso RichardSee Remarks08/15/20223,935
Sharei ArmonPresident and CEO06/30/20226,585
Knopf Lawrence JGeneral Counsel06/30/20224,011
Capasso RichardSee Remarks06/30/20223,198
Jensen Klavs F.Director05/25/202250,428
Sharei ArmonPresident and CEO01/12/202223,530
Sharei ArmonPresident and CEO12/31/202112,798
Knopf Lawrence JGeneral Counsel12/31/20213,446
SCHULMAN AMY WDirector12/22/202184,823
Sharei ArmonPresident and CEO12/22/202119,999
SCHULMAN AMY WDirector12/13/202140,367
Sharei ArmonPresident and CEO02/27/202114,480
Sharei ArmonPresident and CEO01/08/20214,525
Temasek Holdings (Private) Ltd10% Owner11/03/202010,000,000
AMERICAN INTERNATIONAL GROUP INC10% Owner11/03/202010,000,000
SCHULMAN AMY WDirector11/03/20204,000,000
Polaris Management Co. VII, L.L.C.10% Owner11/03/20204,000,000
Invus Public Equities, L.P.10% Owner11/03/20207,440,000
AMERICAN INTERNATIONAL GROUP INC10% Owner10/30/202010,000,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR SQZ BIOTECHNOLOGIES CO
STOCK BUYBACKS FOR SQZ BIOTECHNOLOGIES CO
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2023
12/31/2022
0.16%
1Q
03/31/2023
09/30/2022
0.71%
2Q
03/31/2023
06/30/2022
3.96%
3Q
03/31/2023
03/31/2022
4.78%
4Q
03/31/2023
12/31/2021
5.14%
5Q
03/31/2023
09/30/2021
5.14%
6Q
03/31/2023
06/30/2021
5.63%
7Q
03/31/2023
03/31/2021
12.29%
8Q
Load More

Period of Report: 03/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2022
0.16%
1Q
09/30/2022
0.71%
2Q
06/30/2022
3.96%
3Q
03/31/2022
4.78%
4Q
12/31/2021
5.14%
5Q
09/30/2021
5.14%
6Q
06/30/2021
5.63%
7Q
03/31/2021
12.29%
8Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR SQZ BIOTECHNOLOGIES CO
LOADING...